Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at [email protected] Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to Stelara

Written By Farhat Nasim23 Oct 2025 1:38 PM IST

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that Health Canada has granted a Notice of Compliance (NOC) for...

Luxury Cars for Employees: This Pharma Firm's Diwali Giveaway Goes Viral

Written By Farhat Nasim22 Oct 2025 9:22 PM IST

Chandigarh: A Chandigarh-based pharmaceutical company created a buzz ahead of Diwali by gifting 51 brand-new luxury cars and SUVs to its top...

IGGMC resident doctor accuses forensic dept professor of sexual, mental harassment, Central MARD demands action

Bengaluru Dermatologist Sent to Judicial Custody After 21-Year-Old Alleges Sexual Harassment During Skin Examination

Written By Farhat Nasim21 Oct 2025 5:25 PM IST

Bengaluru: A dermatologist has been arrested for allegedly sexually harassing a 21-year-old woman during a consultation at his private clinic in...

USFDA Approves Eli Lillys Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales

Written By Farhat Nasim10 Oct 2025 3:46 PM IST

New Delhi: In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just six months of...

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

Written By Farhat Nasim30 Sept 2025 3:09 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...

Paracetamol Market 2025: DOLO-650 the Top Prescribed brand, suggests industry data

Written By Farhat Nasim1 Sept 2025 3:07 PM IST

New Delhi: Micro Labs' flagship paracetamol brand, DOLO-650, has cemented its position as the top-selling paracetamol in the country with sales of Rs...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma Recalls Testosterone Gel In US Market

Written By Farhat Nasim5 April 2025 1:27 PM IST

The Chestnut Ridge-based drugmaker, a part of Bengaluru-based Strides Pharma Science, is recalling the affected lot due to the 'Presence of Benzene'.

AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market

AbbVie Lowers 2025 Earnings Forecast After USD 20 Billion Acquisition Spree

Written By Farhat Nasim5 April 2025 11:15 AM IST

AbbVie has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection in 2023.

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

Bayer Takes Roundup Cancer Case Back to Supreme Court

Written By Farhat Nasim5 April 2025 10:45 AM IST

Bayer has warned U.S. lawmakers it might halt Roundup sales to farmers, unless they can strengthen legal protection against the litigation.

Traveres Filspari Becomes First USFDA-Approved Drug for FSGS Treatment

Sanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management

Written By Farhat Nasim17 Feb 2025 7:56 PM IST

New Delhi: Sanofi has received U.S. Food and Drug Administration (FDA) approval for Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin...

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

Johnson & Johnson Halts Late-Stage Trial of ExPEC9V Vaccine for Sepsis, Blood Infections

Written By Farhat Nasim17 Feb 2025 7:01 PM IST

No safety signals related to the experimental vaccine were identified, J&J said.

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK's Meningococcal Vaccine Penmenvy Approved by USFDA

Written By Farhat Nasim17 Feb 2025 5:19 PM IST

Bengaluru: The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok